UNSPSC 51383401: Acemetacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C21H18ClNO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V141XK28X, chemically known as 1h-indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, carboxymethyl ester but generally known as acemetacin, which bears US NIH Compound Identifier 1981. European Medicines Agency schedules Acemetacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05209MIG.

UNSPSC 51383401 Acemetacin (Commodity) shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems, which fall outside the acemetacin drug classification and do not reflect actual purchasing under this code. State and local health agencies, county community health departments, and municipalities may procure pharmaceutical products through this code tier, but current activity does not demonstrate sustained demand for acemetacin specifically.

The Seminole County opportunity, posted June 30, 2026 with a response deadline of July 26, 2026, sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders were required to submit electronically through the county's e-Procurement Portal, include all shipping and delivery costs, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract offered a two-year initial term with an optional one-year renewal. The code shows little demonstrable recent activity outside this single mismatched solicitation, indicating this commodity tier does not currently capture meaningful state and local purchasing volume for acemetacin or related non-steroidal anti-inflammatory drugs.